Early Breast Cancer
Study title
POSNOC
Speciality
Oncology
Description
To assess whether adjuvant therapy alone is no worse than adjuvant therapy plus axillary treatment, in terms of axillary recurrence within 5 years.
Eligibility criteria
To be considered for the study you must meet the following criteria:
- 50 years of age or older
- Have histologically confirmed breast cancer
- Nodal involvement
Study details
The study will compare adjuvant therapy alone with adjuvant therapy plus axillary treatment (axillary node clearance (ANC) or axillary radiotherapy (ART)).
Your participation in this study will be for approximately 5 years.
Sign up to this clinical trial below.
Further information
Centres
- Newcastle (Oncology) - Newcastle
- Fiona Stanley Hospital (Oncology) - Perth
Loading...